Preparation and preliminary biological evaluation of a 177Lu labeled nitroimidazole derivative for possible use in targeted tumor therapy

Radiochimica Acta

Volumn 94, Issue 6-7, 2006, Pages 375-380

  Das, Tapas ^a   Chakraborty, Sudipta ^a   Banerjee, Sharmila ^a   Sarma, Haladhar D ^a   Samuel, Grace ^a   Venkatesh, Meera ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

177Lu; Metronidazole; Tumor hypoxia

Indexed keywords

EID: 33745381942     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2006.94.6.375     Document Type: Conference Paper

References (29)

1. Nunn, A., Linder, K., Strauss, H. W.: Nitroimidazoles and imaging hypoxia. Eur. J. Nucl. Med. 22, 265 (1995).
2. Van-Wiele, C. V., Signore, A., Scopinaro, F., Warerhouse, R., Dierckx, R. A.: Imaging tumor hypoxia: Where are we? Nucl. Med. Biol. 28, 945 (2001).
3. Moulder, J. E., Rockwell, S.: Tumor hypoxia: Its implication on cancer therapy. Cancer Metast. Rev. 5, 313 (1987).
4. Hodgkiss, R. J.: Use of 2-nitroimidazoles as a bioreductive markers for tumor hypoxia. Anti-Cancer Drug Des. 13, 687 (1998).
5. Chu, T., Hu, S., Wei, B., Wang, Y., Liu, X., Wang, X.: Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia. Bioorg. Med. Chem. Lett. 14, 747 (2004).
6. Brown, J. M.: Hypoxic cell radiosensitizers: What next? Int. J. Radiat. Oncol. Biol. Phys. 16, 987 (1989).
7. Chapman, J. D.: Hypoxic sensitizers: Implications for radiation therapy. N. Engl. J. Med. 301, 1429 (1979).
8. 99mTc-labeled modified metronidazole: A potential agent for imaging hypoxia. Nucl. Med. Biol. 30, 127 (2003).
9. 82Br]bromomisonidazole. Int. J. Nucl. Med. Biol. 10, 205 (1983).
10. Biskupiak, J. E., Grierson, J. R., Rasey, J. S., Martin, G. V., Krohn, K. A.: Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging. J. Med. Chem. 34, 2165 (1991).
11. 18F-labeled misonidazole: Potential in vivo markers of hypoxic tissues. Appl. Radiat. Isot. 37, 599 (1986).
12. 18F]-fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phy. 22, 199 (1991).
13. Ballinger, J. R., Min-Kee, J. W., Rauth, A. M.: in vitro and in vivo evaluation of a technetium-99m labeled 2-nitroimidazole (BMS 181 321) as marker of tumor hypoxia. J. Nucl. Med. 37, 1023 (1996).
14. 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors. J. Nucl. Med. 41, 169 (2000).
15. 2: an in vitro/in vivo assesment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl. Med. Biol. 30, 101 (2003).
16. 3]octreotate for somatostatin receptor-targeted radionuclide therapy. Int. J. Cancer. 92, 628 (2001).
17. 177Lu-DOTA- Lanreotide: A novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 31, 753 (2004).
18. 177Lu for radionuclide therapy. Appl. Radiat. Isot. 59, 109 (2003).
19. Volkert, W. A., Hoffman, T. J.: Therapeutic radiopharmaceuticals. Chem. Rev. 99, 2269 (1999).
20. Liu, S., Edwards, D. S.: Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconj. Chem. 12, 7 (2001).
21. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., Johnson, R. S.: Hypoxia-inducible factor-1 is a positive factor in solid tumor growth. Cancer Res. 60, 4010 (2000).
22. th Edn., Longman Scientific Group, London (1994) p. 407.
23. 99mTc complexes of modified cysteine ligands and bifunctional chelating agents. Nucl. Med. Biol. 26, 555 (1999).
24. th Edn. (V. S. Shirley, ed.) John Wiley and Sons, New York (1996).
25. Knapp, F. F., Ambrose, K. R., Beets, A. L., Luo, H., McPherson, D. W., Mirzadeh, S.: Nuclear Medicine Program Progress Report for Quarter Ending September 30 (1995). Oak-Ridge National Laboratory (1995) p. 6.
26. Neves, M., Kling, A., Lambrecht, R. M.: Radionuclide production for therapeutic radiopharmaceuticals. Appl. Radiat. Isot. 57, 657 (2002).
27. 177Lu for radioimmunotherapeutic applications. Nucl. Med. Biol. 29, 431 (2002).
28. Strauss, A. W., Nunn, A., Linder, K.: Nitroimidazoles for imaging hypoxic myocardium. J. Nucl. Cadiol. 2, 437 (1995).
29. Grunbaum, Z., Freauff, S. J., Krohn, K. A., Wilbur, D. S., Magee, S., Rasey, J.: Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J. Nucl. Med. 28, 68 (1987).